Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Lamivudine/nevirapine/zidovudine

Reactive arthritis immune reconstitution inflammatory syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Katusiime C. A rare entity of reactive arthritis-immune reconstitution inflammatory syndrome in an immunocompromised patient. Clinical Case Reports 7: 1481-1483, No. 8, 23 Jun 2019. Available from: URL: http://doi.org/10.1002/ccr3.2258 - Uganda Katusiime C. A rare entity of reactive arthritis-immune reconstitution inflammatory syndrome in an immunocompromised patient. Clinical Case Reports 7: 1481-1483, No. 8, 23 Jun 2019. Available from: URL: http://​doi.​org/​10.​1002/​ccr3.​2258 - Uganda
Metadaten
Titel
Lamivudine/nevirapine/zidovudine
Reactive arthritis immune reconstitution inflammatory syndrome: case report
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-68968-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Denosumab

Case report

Adalimumab